Imunon (IMNN) CFO reports initial option and share holdings

Rhea-AI Filing Summary

Imunon, Inc. filed an initial insider ownership report for its CFO, Jeffrey Wayne Church, showing his current holdings in the company. He directly holds 26 shares of common stock. In addition, he holds two stock option awards: one option to purchase 167 shares of common stock at $9.20 per share, exercisable beginning on 08/04/2025 and expiring on 08/04/2035, and another option to purchase 5,000 shares of common stock at $3.95 per share, exercisable beginning on 01/02/2026 and expiring on 01/02/2036. The options vest so that half vests on the grant date, a quarter on the first anniversary, and the remaining quarter on the second anniversary.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

CHURCH JEFFREY WAYNE

(Last) (First) (Middle)

C/O IMUNON, INC.

997 LENOX DRIVE, SUITE 100

(Street)

LAWRENCEVILLE NJ 08648

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/15/2026

3. Issuer Name and Ticker or Trading Symbol
Imunon, Inc. [ IMNN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	26	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	08/04/2025(1)	08/04/2035	Common Stock	167	$9.2	D
Stock Option (Right to Buy)	01/02/2026(1)	01/02/2036	Common Stock	5,000	$3.95	D

Explanation of Responses:

1. The options vest as follows: 1/2 on the date of grant; 1/4 on the one year anniversary of the date of grant; and 1/4 on the second year anniversary of the date of grant.

	/s/ Susan Eylward, Attorney-in-Fact for Jeffrey Church	01/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What does Imunon (IMNN) disclose in this Form 3 filing?

The filing reports CFO Jeffrey Wayne Church’s initial beneficial ownership in Imunon, Inc., including his common stock and stock option holdings as of 01/15/2026.

How many Imunon (IMNN) common shares does the CFO directly own?

The CFO directly owns 26 shares of Imunon common stock, reported as beneficially owned in direct form.

What stock options does the Imunon (IMNN) CFO hold according to the Form 3?

He holds two stock options: one for 167 shares at $9.20 per share expiring on 08/04/2035, and one for 5,000 shares at $3.95 per share expiring on 01/02/2036.

When do the Imunon (IMNN) CFO’s options begin to vest and become exercisable?

The options vest as follows: 1/2 on the grant date, 1/4 on the first anniversary, and 1/4 on the second anniversary, with exercisability beginning on 08/04/2025 and 01/02/2026, respectively.

Are the Imunon (IMNN) CFO’s holdings reported as direct or indirect ownership?

All reported holdings, including the 26 common shares and both stock option awards, are listed as direct (D) ownership.

Does this Imunon (IMNN) Form 3 indicate any transactions like insider buying or selling?

No transactions are reported; the Form 3 lists holdings only, serving as the initial statement of the CFO’s beneficial ownership.